Position in ACB
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$264,076
-$26,689 QoQ
Shares Held
94,651
+6.4% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 149 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $359,418,700 across 12 Drug Manufacturers - Specialty & Generic names. ACB ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,525,432 | $109,617,543 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
168,649 | $91,379,087 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
653,736 | $72,525,471 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,470,258 | $36,183,049 | |
| 5 | VTRS |
Viatris Inc
|
997,741 | $15,844,127 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
367,355 | $12,445,987 | |
| 7 | ALKS |
Alkermes plc.
|
118,432 | $6,205,836 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
34,973 | $5,894,349 |
All Filings in ACB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $264,076 | 94,651 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $290,765 | 88,919 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $330,236 | 78,255 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $433,500 | 72,735 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $294,523 | 69,463 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $267,566 | 60,949 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $249,169 | 58,628 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $328,927 | 55,940 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $255,042 | 55,204 | Shares | Sole | 2024-08-02 | |
| 2023-12-31 | $210,511 | 442,250 | Shares | Sole | 2024-02-12 | |
| 2023-03-31 | $183,160 | 262,784 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $222,736 | 241,318 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $218,724 | 179,282 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $928,990 | 703,781 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,263,128 | 565,782 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,310,844 | 611,986 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,560,280 | 659,000 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,526,495 | 611,338 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,835,731 | 626,824 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,699,778 | 565,557 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,700,146 | 365,623 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $4,092,489 | 329,508 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,942,895 | 3,248,229 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||